Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020

被引：2
|
作者：
Moneer, Osman [1 ,2 ]
Lee, ChangWon C. [1 ]
Avorn, Jerry [1 ]
Kesselheim, Aaron S. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon,Program Regu, Boston, MA 02115 USA
[2] Yale Univ, Yale Sch Med, New Haven, CT USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2021.8530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This cross-sectional study uses data from the US Food and Drug Administration (FDA) to review the postmarketing requirements and commitments attached to new vaccines approved for use in the past 15 years in the United States.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
    Fei Liang
    Sheng Zhang
    Qin Wang
    Wenfeng Li
    BMC Cancer, 20
  • [42] Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
    Tibau, Ariadna
    Molto, Consolacion
    Ocana, Alberto
    Templeton, Arnoud J.
    Del Carpio, Luis P.
    Del Paggio, Joseph C.
    Barnadas, Agusti
    Booth, Christopher M.
    Amir, Eitan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (05): : 486 - 492
  • [43] A COMPARISON OF ANTIEPILEPTIC DRUGS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION AND HEALTH CANADA
    Alsharaimy, F.
    Chong, D.
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    Eguale, T.
    VALUE IN HEALTH, 2017, 20 (05) : A199 - A199
  • [44] US Food and Drug Administration and Design of Drug Approval Studies
    Woloshin, Steven
    Schwartz, Lisa M.
    Frankel, Brittney
    Faerber, Adrienne
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (20): : 2163 - 2165
  • [45] Vaccines, pharmaceutical products, and bioterrorism: Challenges for the US Food and Drug Administration
    Zoon, KC
    EMERGING INFECTIOUS DISEASES, 1999, 5 (04) : 534 - 536
  • [46] Patient-Reported Outcomes in Orphan Drug Labels Approved by the US Food and Drug Administration
    Hong, Yoon Duk
    Villalonga-Olives, Ester
    Perfetto, Eleanor M.
    VALUE IN HEALTH, 2019, 22 (08) : 925 - 930
  • [47] Integrating New Effectiveness Data Into US Food and Drug Administration-Approved Drug Labeling
    Gyawali, Bishal
    Darrow, Jonathan J.
    Kesselheim, Aaron S.
    JAMA INTERNAL MEDICINE, 2021, 181 (07) : 897 - 898
  • [48] Postmarketing requirements for drugs approved by the Food and Drug Administration for the treatment of solid tumor cancers, 2010-2019.
    Jeune-Smith, Yolaine
    Zettler, Marjorie E.
    Fortier, Stephanie
    Rupard, Skyler
    Gajra, Ajeet
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] The Food and Drug Administration Amendments Act and Postmarketing Commitments
    Fain, Kevin
    Daubresse, Matthew
    Alexander, G. Caleb
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (02): : 202 - 204
  • [50] Pediatric Drug Development Studies for Familial Hypercholesterolemia Submitted to the US Food and Drug Administration Between 2007 and 2020
    Park, Kyunghun
    Vishnevetskaya, Kristina
    Vaidyanathan, Jayabharathi
    Burckart, Gilbert J.
    Green, Dionna J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (03): : 397 - 408
12345